Avanos Medical Inc [AVNS] stock is trading at $11.24, up 1.08%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The AVNS shares have lost -3.60% over the last week, with a monthly amount drifted -4.42%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Avanos Medical Inc [NYSE: AVNS] stock has seen the most recent analyst activity on July 25, 2023, when KeyBanc Capital Markets downgraded its rating to a Sector Weight. Previously, CL King started tracking the stock with Buy rating on May 22, 2023, and set its price target to $31. On August 04, 2021, downgrade downgraded it’s rating to Equal-Weight and revised its price target to $45 on the stock. Barclays upgraded its rating to a Equal Weight but stick to its price target of $30 on April 13, 2020. Stifel downgraded its rating to a Hold and reduced its price target to $35 on November 07, 2019. Raymond James downgraded its rating to Mkt Perform for this stock on November 06, 2019. In a note dated October 16, 2018, Barclays initiated an Equal Weight rating and provided a target price of $69 on this stock.
Avanos Medical Inc [AVNS] stock has fluctuated between $9.30 and $19.91 over the past year. Currently, Wall Street analysts expect the stock to reach $23 within the next 12 months. Avanos Medical Inc [NYSE: AVNS] shares were valued at $11.24 at the most recent close of the market. An investor can expect a potential return of 104.63% based on the average AVNS price forecast.
Analyzing the AVNS fundamentals
Avanos Medical Inc [NYSE:AVNS] reported sales of 699.90M for the trailing twelve months, which represents a growth of 4.34%. Gross Profit Margin for this corporation currently stands at 0.52% with Operating Profit Margin at 0.04%, Pretax Profit Margin comes in at -0.7%, and Net Profit Margin reading is -0.67%. To continue investigating profitability, this company’s Return on Assets is posted at -0.44, Equity is -0.58 and Total Capital is 0.03. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.17.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 11.00 points at the first support level, and at 10.76 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.40, and for the 2nd resistance point, it is at 11.56.
Ratios To Look Out For
For context, Avanos Medical Inc’s Current Ratio is 2.38. Further, the Quick Ratio stands at 1.36, while the Cash Ratio is 0.48. Considering the valuation of this stock, the price to sales ratio is 0.75, the price to book ratio is 0.67.
Transactions by insiders
Recent insider trading involved Holbrook Kerr, Former Officer, that happened on Nov 18 ’25 when 15000.0 shares were purchased. Director, BLACKFORD GARY completed a deal on Aug 13 ’25 to buy 40000.0 shares. Meanwhile, Director BLACKFORD GARY bought 20000.0 shares on Aug 13 ’25.
